MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19
![](https://img.etimg.com/thumb/msid-82274002,width-1070,height-580,imgsize-163795,overlay-economictimes/photo.jpg)
MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufacturers -- Cipla, Dr Reddy's Laboratories, Emcure Pharmaceuticals, Hetero Labs and Sun Pharmaceutical Industries, it added.
via Economictimes
Post a Comment